Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cellebrite DI Ltd. passes the test. Thus, it seems as though Cellebrite DI Ltd. shares could have potential in the weeks and months to come. Earnings were strong last quarter. SPX Technologies, Inc. beat our consensus estimate by 17.92%, and for the current fiscal year, SPXC is expected to post earnings of $5.37 per share on revenue of $2 billion. The Technology Service ...